Tofacitinib Ups Cancer, Cardiovascular Risks, FDA Warns
Agency to make recommendations after reviewing ORAL Surveillance results The FDA issued a Drug...
Feb 5, 2021
Agency to make recommendations after reviewing ORAL Surveillance results The FDA issued a Drug...
Sep 24, 2020
Agency warns of potential for life-threatening withdrawal reactions WASHINGTON — The FDA is...
Sep 3, 2020
Agency calls on drug manufacturers to remain vigilant for NDMA, other impurities WASHINGTON...
Jun 1, 2020
Agency recommends voluntary recall of some extended release pills WASHINGTON —The FDA recommended that five manufacturers voluntarily recall several lots of the extended-release (ER) formulation of metformin after...